Trial intelligence / Profile preview

Phase II study of autologous adipose-derived mesenchymal stem cells for female stress urinary incontinence

2010-024331-16Phase 2Completed

Sponsor
FIBHULP
Start
Dec 2011
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in stress urinary incontinence (SUI), sponsored by FIBHULP. Started Dec 2011; status: completed.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

stress urinary incontinence (SUI)

Beyond the preview

Go deeper on 2010-024331-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024331-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call